[17] Tirzepatide [edit] Tirzepatide is an analog of the human GIP hormone with a C 20 fatty diacid portion attached, that has been approved for treatment of diabetes in the US in May 2022
Affected individuals are encouraged to contact King Law to discuss whether they meet the criteria to take legal action
Medication Coverage Commercial insurance: Most major insurers now cover FDA-approved weight-loss medications (Wegovy, Saxenda, Mounjaro) with prior authorization
From a psychological, social, and medical standpoint, managing PD is challenging for younger patients and their families
See Supplementary Table 1 for data collection parameters
(2) Evidence on B12 and cancer is mixed overall, with some studies showing higher risk, some lower, and some none